title: BRAF inhibition in refractory hairy-cell leukemia.
authors.forename: Sascha
authors.initials: S
authors.lastname: Dietrich
authors.forename: Hanno
authors.initials: H
authors.lastname: Glimm
authors.forename: Mindaugas
authors.initials: M
authors.lastname: Andrulis
authors.forename: Christof
authors.initials: C
authors.lastname: von Kalle
authors.forename: Anthony D
authors.initials: AD
authors.lastname: Ho
authors.forename: Thorsten
authors.initials: T
authors.lastname: Zenz
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007943:Leukemia, Hairy Cell / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009154:Mutation; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors* / Q000235:genetics; D012074:Remission Induction; D013449:Sulfonamides / Q000627:therapeutic use*; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf